Trial Profile
Skin-related adverse events in patients receiving vemurafenib
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Oct 2015
Price :
$35
*
At a glance
- Drugs Vemurafenib (Primary)
- Indications Malignant melanoma
- Focus Adverse reactions
- 19 Oct 2015 New trial record